课题基金 / 基金详情

EFFECTS OF SURGERY FOR HYPERTROPHIC CARDIOMYOPATHY ON EXERCISE HEMODYNAMICS

EFFECTS OF SURGERY FOR HYPERTROPHIC CARDIOMYOPATHY ON EXERCISE HEMODYNAMICS
肥厚型心肌病手术对运动血流动力学的影响
批准号:
3899262
负责人:
R O CANNON
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

R O CANNON的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Surgery for obstructive hypertrophic cardiomyopathy (septal myotomy/myectomy or mitral valve replacement) improves symptoms in many, but not all patients with hypertrophic cardiomyopathy. To assess which hemodynamic changes before and following surgery best correlate with exercise benefit following surgery, 14 patients with hypertrophic cardiomyopathy underwent treadmill exercise testing (Bruce protocol) with measurement of maximum oxygen consumption before and 6 months following surgery. The post-operative exercise study demonstrated improved exercise duration but with only a marginal improvement in maximum oxygen consumption. The improvement in maximum oxygen consumption following surgery compared to the preoperative study correlated directly with the magnitude of reduction in left ventricular outflow gradient and left ventricular end-diastolic pressure. The 5 patients with no improvement in maximum oxygen consumption, including 2 with greater than 50 mmHg gradient reduction, had less than 5 mmhg reduction in left ventricular end-diastolic pressure. Seven of the 9 patients with increased post-operative maximum oxygen consumption had a gradient reduction greater than or equal to 65 mmhg; the 2 with lesser gradient reduction had greater than 8 mmhg reduction in left ventricular end-diastolic pressure. Thus, benefit in exercise capacity following surgery may be determined as much by the reduction in the left ventricular filling pressures as by the magnitude of gradient reduction following surgery.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EFFECT OF SURGICAL RELIEF OF OBSTRUCTION IN HYPERTROPHIC CARDIOMYOPATHY
HORMONE THERAPY AND INFLAMMATORY CELL ADHESION MOLECULES
ABNORMAL ESOPHAGEAL MOTILITY IN PATIENTS WITH LIMITED CORONARY FLOW RESERVE
DETRIMENTAL EFFECT OF ERGONOVINE IN HYPERTROPHIC CARDIOMYOPATHY